Stock GYRE GYRE THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases Gyre Therapeutics, Inc.

Equities

GYRE

US4037831033

End-of-day quote Nasdaq
Other stock markets
 23:00:00 22/05/2024 BST 		5-day change 1st Jan Change
12.61 USD -6.87% Intraday chart for Gyre Therapeutics, Inc. -12.61% -50.91%
05-09 Gyre Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
04-03 Gyre Therapeutics Insider Sold Shares Worth $323,000, According to a Recent SEC Filing MT

Press Releases

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Gyre Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
GL
Gyre Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
AQ
Gyre Therapeutics Reports Full Year 2023 Financial Results and Provides Business Update
GL
Gyre Therapeutics Expands Board of Directors with Appointment of Rodney L. Nussbaum
GL
Totus Medicines Announces Appointment of Nassim Usman, Ph.D., as President & CEO and the Closing of a $66M Series B Funding
PR
Gyre Therapeutics Presents Poster at the American Association for the Study of Liver Diseases (AASLD) Annual Liver Meeting
GL
Gyre Therapeutics Presents Poster at the American Association for the Study of Liver Diseases (AASLD) Annual Liver Meeting
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. GYRE Stock
  4. News Gyre Therapeutics, Inc.
  5. Press Releases